Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care

[1]  M. Bozzetti,et al.  p16 INK4a and Ki67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection. , 2014, Pathology, research and practice.

[2]  Z. Maleki,et al.  Utility of P16 expression and Ki‐67 proliferation index in ASCUS and ASC‐H pap tests , 2014, Diagnostic cytopathology.

[3]  Z. Baloch,et al.  Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid‐based cervical cytology , 2014, Diagnostic cytopathology.

[4]  M. von Knebel Doeberitz,et al.  Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study , 2013, Journal of the National Cancer Institute.

[5]  Hy-Sook Kim,et al.  Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion , 2013, Virchows Archiv.

[6]  C. Cohen,et al.  Evaluation of CINtec PLUS® testing as an adjunctive test in ASC‐US diagnosed SurePath® preparations , 2013, Diagnostic cytopathology.

[7]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[8]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[9]  E. Pescarmona,et al.  p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. , 2012, Gynecologic oncology.

[10]  N. Saba,et al.  Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck , 2012, Journal of oncology.

[11]  D. Malinowski,et al.  Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening Programs , 2012, Journal of oncology.

[12]  Meenakshi Singh,et al.  Immunocytochemical colocalization of p16INK4a and Ki‐67 predicts CIN2/3 and AIS/adenocarcinoma , 2012, Cancer cytopathology.

[13]  J. Ordi,et al.  Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. , 2011, Gynecologic oncology.

[14]  J. Bogers,et al.  BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[15]  R. Gibb,et al.  The impact of liquid-based cytology in decreasing the incidence of cervical cancer. , 2011, Reviews in obstetrics & gynecology.

[16]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[17]  M. Hirsch,et al.  MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA. , 2010, Diagnostic histopathology.

[18]  L. Ylagan,et al.  Role of ProExC: A Novel Immunoperoxidase Marker in the Evaluation of Dysplastic Squamous and Glandular Lesions in Cervical Specimens , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  Y. Erozan,et al.  The Bethesda System for Reporting Cervical Cytology , 2004, Acta Cytologica.

[20]  C. Thorns,et al.  p16INK4A in routine practice as a marker of cervical epithelial neoplasia. , 2009, Gynecologic oncology.

[21]  S. Franceschi,et al.  Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. , 2008, European journal of cancer.

[22]  M. Wilkerson,et al.  Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. , 2007, Human pathology.

[23]  Jane L. Meyer,et al.  Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay , 2007, Cancer.

[24]  L. Mariani,et al.  Over-Expression of Topoisomerase II&agr; is Related to the Grade of Cervical Intraepithelial Neoplasia (CIN) and High-Risk Human Papillomavirus (HPV), but does not Predict Prognosis in Cervical Cancer or HPV Clearance after Cone Treatment , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[25]  U. Singh,et al.  MIB‐1 and PCNA immunostaining as a diagnostic adjunct to cervical Pap smear , 2005, Diagnostic cytopathology.

[26]  D. Malinowski.  Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease. , 2005, BioTechniques.

[27]  M. Pagano,et al.  Skp2, the FoxO1 hunter. , 2005, Cancer cell.

[28]  E. Unger,et al.  Human Papillomavirus and Cervical Cancer , 2004, Emerging infectious diseases.

[29]  Diane Solomon,et al.  The Bethesda System for Reporting Cervical Cytology , 2004 .

[30]  E. van Marck,et al.  Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? , 2003, Journal of clinical pathology.

[31]  S. Naudé,et al.  Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. , 2002, Gynecologic oncology.

[32]  G. Priore,et al.  MIB-1 Expression in Cervical Papanicolaou Tests Correlates With Dysplasia in Subsequent Cervical Biopsies , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[33]  B. Quade,et al.  Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia , 2001, The American journal of surgical pathology.

[34]  M. Schiffman,et al.  Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. , 2001, JAMA.

[35]  I. Novikov,et al.  Expression of topoisomerase II and Ki‐67 in cervical carcinoma — clinicopathological study using immunohistochemistry , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  A. Kovatich,et al.  Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. , 1997, Gynecologic oncology.

[37]  C. Meijer,et al.  The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. , 1995, The Journal of general virology.

[38]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .